Celsion Corp.
(NASDAQ : CLSN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. 4.56%378.318.2%$1034.33m
ABTAbbott Laboratories 3.17%95.020.8%$681.99m
BDXBecton, Dickinson & Co. 2.27%246.971.0%$635.38m
DHRDanaher Corp. 1.51%166.440.7%$595.38m
MDTMedtronic Plc 0.61%98.740.6%$552.61m
TMOThermo Fisher Scientific, Inc. 1.81%348.941.0%$507.16m
INOInovio Pharmaceuticals, Inc. 10.49%14.756.3%$439.97m
BSXBoston Scientific Corp. 1.36%37.981.1%$409.30m
ISRGIntuitive Surgical, Inc. 1.34%580.032.4%$370.20m
SYKStryker Corp. 0.23%195.791.3%$362.87m
WSTWest Pharmaceutical Services, Inc. 5.30%216.941.6%$307.41m
ALGNAlign Technology, Inc. -1.43%245.626.4%$296.78m
BAXBaxter International, Inc. 2.00%89.961.8%$262.76m
EWEdwards Lifesciences Corp. 1.09%224.561.2%$220.18m
QDELQuidel Corp. 4.65%175.007.7%$217.06m

Company Profile

Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.